Cite
HARVARD Citation
Guillo, L. et al. (2022). Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet gastroenterology and hepatology. pp. 254-261. [Online].